Insider · CIK 0001777938
Ryan Spencer
ceoofficerdirector
Files at DVAX (DYNAVAX TECHNOLOGIES CORP), CDTX (Cidara Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | CDTX Cidara Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,100 | $0.00 | $0 | 11,100 | Jun 18, 2025 |
| Feb 18, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Common Stock | +55,000 | - | - | 297,261 | Feb 20, 2025 |
| Feb 18, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | FTax withholding Common Stock | -36,528 | $12.93 | $472k | 260,733 | Feb 20, 2025 |
| Feb 18, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Restricted Stock Unitderivative | -55,000 | - | - | 110,000 | Feb 20, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Common Stock | +62,500 | - | - | 273,522 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | FTax withholding Common Stock | -31,694 | $12.69 | $402k | 242,261 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | AGrant or award Restricted Stock Unitderivative | +62,500 | - | - | 62,500 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Restricted Stock Unitderivative | -62,500 | - | - | 0 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | AGrant or award Stock Option (Right to Buy)derivative | +225,000 | - | - | 225,000 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | AGrant or award Restricted Stock Unitderivative | +136,000 | - | - | 136,000 | Feb 18, 2025 |
| Feb 10, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Common Stock | +20,833 | - | - | 222,231 | Feb 12, 2025 |
| Feb 10, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | FTax withholding Common Stock | -11,209 | $13.20 | $148k | 211,022 | Feb 12, 2025 |
| Feb 10, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Restricted Stock Unitderivative | -20,833 | - | - | 0 | Feb 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.